C16 Biosciences

C16 Biosciences is a biotechnology firm that uses microbiology to brew sustainable alternatives to palm oil.

C16 Biosciences has developed technology to brew a sustainable alternative to palm oil from microbes.

C16 Biosciences was founded in 2017 by Shara Ticku, Harry McNamara, and David Heller. The company is headquartered in New York, New York.

C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to conflict palm oil.

C16 uses a proprietary yeast which it feeds with carbon-containing waste. This could include excess food from supermarkets and homes or glycerol from biofuels production.

 

C16 Biosciences is backed by Breakthrough Energy Ventures, Data Collective — DCVC and others. The company raised $20M in a Series A round on Mar 02, 2020. This brings C16 Biosciences' total funding to $24M to date.

 

 

  • Year founded: 2017
  • Funding Info: $24M over 2 Rounds (Latest Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: New York
  • State: New York
  • Country: United States
Related businesses